Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

Assessment of a semi-automated enrichment system (Uroquattro HB&L) for detection of faecal carriers of ESBL-/AmpC-producing Enterobacterales.

Pérez-Palacios P, López-Cerero L, Lupión C, Pascual A.

Enferm Infecc Microbiol Clin. 2019 Dec 6. pii: S0213-005X(19)30313-1. doi: 10.1016/j.eimc.2019.11.001. [Epub ahead of print] English, Spanish.

PMID:
31818497
2.

Tracking KPC-3-producing ST-258 Klebsiella pneumoniae outbreak in a third-level hospital in Granada (Andalusia, Spain) by risk factors and molecular characteristics.

Soria-Segarra C, González-Bustos P, López-Cerero L, Fernández-Cuenca F, Rojo-Martín MD, Fernández-Sierra MA, Gutiérrez-Fernández J.

Mol Biol Rep. 2019 Dec 2. doi: 10.1007/s11033-019-05203-w. [Epub ahead of print]

PMID:
31792747
3.

Association of blaOXA-1, and aac(6')-Ib-cr with ST405 K. pneumoniae clone.

Luque-González P, López-Cerero L, Díaz-de-Alba P, Rodríguez-Martínez JM.

Enferm Infecc Microbiol Clin. 2019 Jun - Jul;37(6):417-418. doi: 10.1016/j.eimc.2018.06.001. Epub 2018 Jul 4. English, Spanish. No abstract available.

PMID:
31155040
4.

Epidemiology of MRSA CC398 in hospitals located in Spanish regions with different pig-farming densities: a multicentre study.

Ceballos S, Aspiroz C, Ruiz-Ripa L, Reynaga E, Azcona-Gutiérrez JM, Rezusta A, Seral C, Antoñanzas F, Torres L, López C, López-Cerero L, Cercenado E, Zarazaga M, Torres C; Study Group of clinical LA-MRSA .

J Antimicrob Chemother. 2019 Aug 1;74(8):2157-2161. doi: 10.1093/jac/dkz180.

PMID:
31098612
5.

First identification of blaNDM-1 carbapenemase in blaOXA-94-producing Acinetobacter baumannii ST85 in Spain.

Fernández-Cuenca F, Pérez-Palacios P, Galán-Sánchez F, López-Cerero L, López-Hernández I, López Rojas R, Arca-Suárez J, Díaz-de Alba P, Rodríguez Iglesias M, Pascual A.

Enferm Infecc Microbiol Clin. 2019 May 4. pii: S0213-005X(19)30156-9. doi: 10.1016/j.eimc.2019.03.008. [Epub ahead of print] English, Spanish.

PMID:
31060865
6.

Multicenter study of clinical non-β-lactam-antibiotic susceptible MRSA strains: Genetic lineages and Panton-Valentine leukocidin (PVL) production.

Ceballos S, Aspiroz C, Ruiz-Ripa L, Azcona-Gutierrez JM, López-Cerero L, López-Calleja AI, Álvarez L, Gomáriz M, Fernández M, Torres C; Study Group of Clinical LA-MRSA; Study Group of Clinical LA-MRSA.

Enferm Infecc Microbiol Clin. 2019 Oct;37(8):509-513. doi: 10.1016/j.eimc.2019.01.015. Epub 2019 Mar 14. English, Spanish.

PMID:
30879606
7.

Recommendations of the Spanish Antibiogram Committee (COESANT) for selecting antimicrobial agents and concentrations for in vitro susceptibility studies using automated systems.

Cantón R, Oliver A, Alós JI, de Benito N, Bou G, Campos J, Calvo J, Canut A, Castillo J, Cercenado E, Domínguez MÁ, Fernández-Cuenca F, Guinea J, Larrosa N, Liñares J, López-Cerero L, López-Navas A, Marco F, Mirelis B, Moreno-Romo MÁ, Morosini MI, Navarro F, Oteo J, Pascual Á, Pérez-Trallero E, Pérez-Vázquez M, Soriano A, Torres C, Vila J, Martínez-Martínez L.

Enferm Infecc Microbiol Clin. 2019 Mar 13. pii: S0213-005X(19)30135-1. doi: 10.1016/j.eimc.2019.01.017. [Epub ahead of print] Review. English, Spanish.

PMID:
30878313
8.

Extended-spectrum β-lactamase-producing Enterobacteriaceae from animal origin and wastewater in Tunisia: first detection of O25b-B23-CTX-M-27-ST131 Escherichia coli and CTX-M-15/OXA-204-producing Citrobacter freundii from wastewater.

Sghaier S, Abbassi MS, Pascual A, Serrano L, Díaz-De-Alba P, Said MB, Hassen B, Ibrahim C, Hassen A, López-Cerero L.

J Glob Antimicrob Resist. 2019 Jun;17:189-194. doi: 10.1016/j.jgar.2019.01.002. Epub 2019 Jan 11.

PMID:
30639890
9.

Duration of Colonization by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Healthy Newborns and Associated Risk Factors: A Prospective Cohort Study.

Rodríguez-Revuelta MJ, López-Cerero L, Serrano L, Luna-Lagares S, Pascual A, Rodríguez-Baño J.

Open Forum Infect Dis. 2018 Nov 20;5(12):ofy312. doi: 10.1093/ofid/ofy312. eCollection 2018 Dec.

10.

A case of pan-resistant Burkholderia cepacia complex bacteremic pneumonia, after lung transplantation treated with a targeted combination therapy.

Cantón-Bulnes ML, Hurtado Martínez Á, López-Cerero L, Arenzana Seisdedos Á, Merino-Bohorquez V, Garnacho-Montero J.

Transpl Infect Dis. 2019 Apr;21(2):e13034. doi: 10.1111/tid.13034. Epub 2019 Jan 1.

PMID:
30548546
11.

Intestinal colonization due to Escherichia coli ST131: risk factors and prevalence.

Morales Barroso I, López-Cerero L, Navarro MD, Gutiérrez-Gutiérrez B, Pascual A, Rodríguez-Baño J.

Antimicrob Resist Infect Control. 2018 Nov 15;7:135. doi: 10.1186/s13756-018-0427-9. eCollection 2018.

12.

OXA-48-Like-Producing Klebsiella pneumoniae in Southern Spain in 2014-2015.

Machuca J, López-Cerero L, Fernández-Cuenca F, Mora-Navas L, Mediavilla-Gradolph C, López-Rodríguez I, Pascual Á.

Antimicrob Agents Chemother. 2018 Dec 21;63(1). pii: e01396-18. doi: 10.1128/AAC.01396-18. Print 2019 Jan.

13.

Vagino-rectal colonization and maternal-neonatal transmission of Enterobacteriaceae producing extended-spectrum β-lactamases or carbapenemases: a cross-sectional study.

Jiménez-Rámila C, López-Cerero L, Aguilar Martín MV, Vera Martín C, Serrano L, Pascual Á, Rodríguez-Baño J.

J Hosp Infect. 2019 Feb;101(2):167-174. doi: 10.1016/j.jhin.2018.09.010. Epub 2018 Sep 22.

PMID:
30248371
14.

Incidence and Risk Factors for Acquisition of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Newborns in Seville, Spain: A Prospective Cohort Study.

Rodríguez-Revuelta MJ, López-Cerero L, Serrano L, Luna-Lagares S, Pascual A, Rodríguez-Baño J.

Int J Antimicrob Agents. 2018 Dec;52(6):835-841. doi: 10.1016/j.ijantimicag.2018.09.007. Epub 2018 Sep 17.

PMID:
30236957
15.

Prevalence of ST131 Clone Producing Both ESBL CTX-M-15 and AAC(6')Ib-cr Among Ciprofloxacin-Resistant Escherichia coli Isolates from Yemen.

Alsharapy SA, Yanat B, Lopez-Cerero L, Nasher SS, Díaz-De-Alba P, Pascual Á, Rodríguez-Martínez JM, Touati A.

Microb Drug Resist. 2018 Jun 8. doi: 10.1089/mdr.2018.0024. [Epub ahead of print]

PMID:
29883247
16.

Control of the spread of resistant pathogens in health centers: Beyond the standard prevention measures.

López-Cerero L.

Enferm Infecc Microbiol Clin. 2018 Apr;36(4):207-208. doi: 10.1016/j.eimc.2018.02.001. Epub 2018 Mar 3. English, Spanish. No abstract available.

PMID:
29510863
17.

Prevalence and transmission dynamics of Escherichia coli ST131 among contacts of infected community and hospitalized patients.

Torres E, López-Cerero L, Morales I, Navarro MD, Rodríguez-Baño J, Pascual A.

Clin Microbiol Infect. 2018 Jun;24(6):618-623. doi: 10.1016/j.cmi.2017.09.007. Epub 2017 Sep 19.

18.

First report of NDM-1-producing clinical isolate of Leclercia adecarboxylata in Spain.

Riazzo C, López-Cerero L, Rojo-Martín MD, Hoyos-Mallecot Y, Fernández-Cuenca F, Martín-Ruíz JL, Pascual-Hernández Á, Naas T, Navarro-Marí JM.

Diagn Microbiol Infect Dis. 2017 Jul;88(3):268-270. doi: 10.1016/j.diagmicrobio.2017.04.013. Epub 2017 May 3.

PMID:
28506721
19.

Bacteraemia due to non-ESBL-producing Escherichia coli O25b:H4 sequence type 131: insights into risk factors, clinical features and outcomes.

Morales-Barroso I, López-Cerero L, Molina J, Bellido M, Navarro MD, Serrano L, González-Galán V, Praena J, Pascual A, Rodríguez-Baño J.

Int J Antimicrob Agents. 2017 Apr;49(4):498-502. doi: 10.1016/j.ijantimicag.2016.12.013. Epub 2017 Feb 28.

PMID:
28257756
20.

Low prevalence of mcr-1 positive Enterobacteriaceae isolates in a health area.

Heras-Cañas VJ, López-Cerero L, Díaz de-Alba P, Pascual Á.

Enferm Infecc Microbiol Clin. 2017 Aug - Sep;35(7):467-468. doi: 10.1016/j.eimc.2016.09.004. Epub 2016 Oct 18. English, Spanish. No abstract available.

PMID:
27769683
21.

Corrigendum to "The global threat of antimicrobial resistance: science for intervention" [New Microbes New Infect 6 (2015): 22-29].

Roca I, Akova M, Baquero F, Carlet J, Cavaleri M, Coenen S, Cohen J, Findlay D, Gyssens I, Heuer OE, Kahlmeter G, Kruse H, Laxminarayan R, Liébana E, López-Cerero L, MacGowan A, Martins M, Rodríguez-Baño J, Rolain JM, Segovia C, Sigauque B, Tacconelli E, Wellington E, Vila J.

New Microbes New Infect. 2015 Sep 10;8:175. doi: 10.1016/j.nmni.2015.09.004. eCollection 2015 Nov.

22.

Characterization of an outbreak due to CTX-M-15-producing Klebsiella pneumoniae lacking the blaOXA-48 gene belonging to clone ST405 in a neonatal unit in southern Spain.

Machuca J, López-Cerero L, Fernández-Cuenca F, Gracia-Ahufinger I, Ruiz-Carrascoso G, Rodríguez-López F, Pascual Á.

J Antimicrob Chemother. 2016 Aug;71(8):2353-5. doi: 10.1093/jac/dkw137. Epub 2016 Apr 26. No abstract available.

PMID:
27118773
23.

Modelling the epidemiology of Escherichia coli ST131 and the impact of interventions on the community and healthcare centres.

Talaminos A, López-Cerero L, Calvillo J, Pascual A, Roa LM, Rodríguez-Baño J.

Epidemiol Infect. 2016 Jul;144(9):1974-82. doi: 10.1017/S0950268816000030. Epub 2016 Feb 3.

PMID:
26838136
24.

Assessment of a phenotypic algorithm to detect plasmid-mediated quinolone resistance in Enterobacteriaceae.

Rodríguez-Martínez JM, López-Cerero L, Díaz-de-Alba P, Chamizo-López FJ, Polo-Padillo J, Pascual Á.

J Antimicrob Chemother. 2016 Mar;71(3):845-7. doi: 10.1093/jac/dkv392. Epub 2015 Nov 26. No abstract available.

PMID:
26612871
25.

Reduced Susceptibility to Cefepime in Clinical Isolates of Enterobacteriaceae Producing OXA-1 Beta-Lactamase.

Torres E, López-Cerero L, Rodríguez-Martínez JM, Pascual Á.

Microb Drug Resist. 2016 Mar;22(2):141-6. doi: 10.1089/mdr.2015.0122. Epub 2015 Aug 21.

PMID:
26295796
26.

Uncoupling between core genome and virulome in extraintestinal pathogenic Escherichia coli.

Fernández-Romero N, Romero-Gómez MP, Mora-Rillo M, Rodríguez-Baño J, López-Cerero L, Pascual Á, Mingorance J.

Can J Microbiol. 2015 Sep;61(9):647-52. doi: 10.1139/cjm-2014-0835. Epub 2015 Feb 11.

PMID:
26063294
27.

The global threat of antimicrobial resistance: science for intervention.

Roca I, Akova M, Baquero F, Carlet J, Cavaleri M, Coenen S, Cohen J, Findlay D, Gyssens I, Heuer OE, Kahlmeter G, Kruse H, Laxminarayan R, Liébana E, López-Cerero L, MacGowan A, Martins M, Rodríguez-Baño J, Rolain JM, Segovia C, Sigauque B, Tacconelli E, Wellington E, Vila J.

New Microbes New Infect. 2015 Apr 16;6:22-9. doi: 10.1016/j.nmni.2015.02.007. eCollection 2015 Jul. Review. Erratum in: New Microbes New Infect. 2015 Nov;8:175.

28.

Performance of EUCAST and CLSI approaches for co-amoxiclav susceptibility testing conditions for clinical categorization of a collection of Escherichia coli isolates with characterized resistance phenotypes.

Díez-Aguilar M, Morosini MI, López-Cerero L, Pascual Á, Calvo J, Martínez-Martínez L, Marco F, Vila J, Ortega A, Oteo J, Cantón R.

J Antimicrob Chemother. 2015 Aug;70(8):2306-10. doi: 10.1093/jac/dkv088. Epub 2015 Apr 21.

PMID:
25900161
29.

Diagnosis and antimicrobial treatment of invasive infections due to multidrug-resistant Enterobacteriaceae. Guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology.

Rodríguez-Baño J, Cisneros JM, Cobos-Trigueros N, Fresco G, Navarro-San Francisco C, Gudiol C, Horcajada JP, López-Cerero L, Martínez JA, Molina J, Montero M, Paño-Pardo JR, Pascual A, Peña C, Pintado V, Retamar P, Tomás M, Borges-Sa M, Garnacho-Montero J, Bou G; Study Group of Nosocomial Infections (GEIH) of the Spanish Society of Infectious Diseases, Infectious Diseases (SEIMC).

Enferm Infecc Microbiol Clin. 2015 May;33(5):337.e1-337.e21. doi: 10.1016/j.eimc.2014.11.009. Epub 2015 Jan 15.

PMID:
25600218
30.

Executive summary of the diagnosis and antimicrobial treatment of invasive infections due to multidrug-resistant Enterobacteriaceae. Guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC).

Rodríguez-Baño J, Cisneros JM, Cobos-Trigueros N, Fresco G, Navarro-San Francisco C, Gudiol C, Horcajada JP, López-Cerero L, Martínez JA, Molina J, Montero M, Paño-Pardo JR, Pascual A, Peña C, Pintado V, Retamar P, Tomás M, Borges-Sa M, Garnacho-Montero J, Bou G; Study Group of Nosocomial Infections (GEIH) of the Spanish Society of Infectious Diseases, Infectious Diseases (SEIMC).

Enferm Infecc Microbiol Clin. 2015 May;33(5):338-41. doi: 10.1016/j.eimc.2014.11.015. Epub 2015 Jan 4.

PMID:
25563393
31.

Epidemiology of infections caused by carbapenemase-producing Enterobacteriaceae: reservoirs and transmission mechanisms.

López-Cerero L, Almirante B.

Enferm Infecc Microbiol Clin. 2014 Dec;32 Suppl 4:10-6. doi: 10.1016/S0213-005X(14)70169-7. Review.

PMID:
25542047
32.

Characterisation of the first ongoing outbreak due to KPC-3-producing Klebsiella pneumoniae (ST512) in Spain.

López-Cerero L, Egea P, Gracia-Ahufinger I, González-Padilla M, Rodríguez-López F, Rodríguez-Baño J, Pascual A.

Int J Antimicrob Agents. 2014 Dec;44(6):538-40. doi: 10.1016/j.ijantimicag.2014.08.006. Epub 2014 Sep 26.

PMID:
25446907
33.

Gentamicin therapy for sepsis due to carbapenem-resistant and colistin-resistant Klebsiella pneumoniae.

Gonzalez-Padilla M, Torre-Cisneros J, Rivera-Espinar F, Pontes-Moreno A, López-Cerero L, Pascual A, Natera C, Rodríguez M, Salcedo I, Rodríguez-López F, Rivero A, Rodríguez-Baño J.

J Antimicrob Chemother. 2015 Mar;70(3):905-13. doi: 10.1093/jac/dku432. Epub 2014 Oct 25.

PMID:
25344809
34.

Assessment of periodontal and opportunistic flora in patients with peri-implantitis.

Albertini M, López-Cerero L, O'Sullivan MG, Chereguini CF, Ballesta S, Ríos V, Herrero-Climent M, Bullón P.

Clin Oral Implants Res. 2015 Aug;26(8):937-941. doi: 10.1111/clr.12387. Epub 2014 Apr 10.

PMID:
24720498
35.

First detection and characterization of an OXA-48-producing Enterobacter aerogenes isolate.

Torres E, López-Cerero L, Del Toro MD, Pascual A.

Enferm Infecc Microbiol Clin. 2014 Aug-Sep;32(7):469-70. doi: 10.1016/j.eimc.2013.10.008. Epub 2013 Dec 17. No abstract available.

PMID:
24355605
36.

[Role of the hospital environment and equipment in the transmission of nosocomial infections].

López-Cerero L.

Enferm Infecc Microbiol Clin. 2014 Aug-Sep;32(7):459-64. doi: 10.1016/j.eimc.2013.10.004. Epub 2013 Dec 4. Spanish.

PMID:
24315300
37.

Escherichia coli belonging to the worldwide emerging epidemic clonal group O25b/ST131: risk factors and clinical implications.

López-Cerero L, Navarro MD, Bellido M, Martín-Peña A, Viñas L, Cisneros JM, Gómez-Langley SL, Sánchez-Monteseirín H, Morales I, Pascual A, Rodríguez-Baño J.

J Antimicrob Chemother. 2014 Mar;69(3):809-14. doi: 10.1093/jac/dkt405. Epub 2013 Oct 11.

PMID:
24123431
38.

Within-lineage variability of ST131 Escherichia coli isolates from humans and companion animals in the south of Europe.

Pomba C, López-Cerero L, Bellido M, Serrano L, Belas A, Couto N, Cavaco-Silva P, Rodríguez-Baño J, Pascual A.

J Antimicrob Chemother. 2014 Jan;69(1):271-3. doi: 10.1093/jac/dkt343. Epub 2013 Sep 10. No abstract available.

PMID:
24022069
39.

Four main virotypes among extended-spectrum-β-lactamase-producing isolates of Escherichia coli O25b:H4-B2-ST131: bacterial, epidemiological, and clinical characteristics.

Blanco J, Mora A, Mamani R, López C, Blanco M, Dahbi G, Herrera A, Marzoa J, Fernández V, de la Cruz F, Martínez-Martínez L, Alonso MP, Nicolas-Chanoine MH, Johnson JR, Johnston B, López-Cerero L, Pascual A, Rodríguez-Baño J; Spanish Group for Nosocomial Infections (GEIH).

J Clin Microbiol. 2013 Oct;51(10):3358-67. doi: 10.1128/JCM.01555-13. Epub 2013 Aug 7.

40.

Impact of the MIC of piperacillin-tazobactam on the outcome of patients with bacteremia due to extended-spectrum-β-lactamase-producing Escherichia coli.

Retamar P, López-Cerero L, Muniain MA, Pascual Á, Rodríguez-Baño J; ESBL-REIPI/GEIH Group.

Antimicrob Agents Chemother. 2013 Jul;57(7):3402-4. doi: 10.1128/AAC.00135-13. Epub 2013 Apr 22.

41.

Outcome of bacteraemia due to extended-spectrum β-lactamase-producing Escherichia coli: impact of microbiological determinants.

Rodríguez-Baño J, Mingorance J, Fernández-Romero N, Serrano L, López-Cerero L, Pascual A; ESBL-REIPI Group.

J Infect. 2013 Jul;67(1):27-34. doi: 10.1016/j.jinf.2013.04.006. Epub 2013 Apr 12.

PMID:
23588104
42.

[Molecular typing methods for infection monitoring and control].

Fernández Cuenca F, López Cerero L, Pascual Hernández Á.

Enferm Infecc Microbiol Clin. 2013 Feb;31 Suppl 1:20-5. doi: 10.1016/S0213-005X(13)70110-1. Spanish.

PMID:
23453227
43.

Inoculum effect on the efficacies of amoxicillin-clavulanate, piperacillin-tazobactam, and imipenem against extended-spectrum β-lactamase (ESBL)-producing and non-ESBL-producing Escherichia coli in an experimental murine sepsis model.

Docobo-Pérez F, López-Cerero L, López-Rojas R, Egea P, Domínguez-Herrera J, Rodríguez-Baño J, Pascual A, Pachón J.

Antimicrob Agents Chemother. 2013 May;57(5):2109-13. doi: 10.1128/AAC.02190-12. Epub 2013 Feb 25.

44.

[The Microbiolgy laboratory in nosocomial infection surveillance and control].

López-Cerero L, Fernández-Cuenca F, Pascual A.

Enferm Infecc Microbiol Clin. 2013 Jan;31(1):44-51. doi: 10.1016/j.eimc.2012.10.001. Epub 2012 Dec 6. Spanish.

PMID:
23218739
45.

Escherichia coli O25b:H4/ST131 are prevalent in Spain and are often not associated with ESBL or quinolone resistance.

López-Cerero L, Bellido Mdel M, Serrano L, Liró J, Cisneros JM, Rodríguez-Baño J, Pascual A.

Enferm Infecc Microbiol Clin. 2013 Jun-Jul;31(6):385-8. doi: 10.1016/j.eimc.2012.09.005. Epub 2012 Nov 20.

PMID:
23182241
46.

Increased raw poultry meat colonization by extended spectrum beta-lactamase-producing Escherichia coli in the south of Spain.

Egea P, López-Cerero L, Torres E, Gómez-Sánchez Mdel C, Serrano L, Navarro Sánchez-Ortiz MD, Rodriguez-Baño J, Pascual A.

Int J Food Microbiol. 2012 Oct 1;159(2):69-73. doi: 10.1016/j.ijfoodmicro.2012.08.002. Epub 2012 Aug 9.

PMID:
23072690
47.

Virulence profiles of bacteremic extended-spectrum β-lactamase-producing Escherichia coli: association with epidemiological and clinical features.

Rodríguez-Baño J, Mingorance J, Fernández-Romero N, Serrano L, López-Cerero L, Pascual A; ESBL-REIPI Group.

PLoS One. 2012;7(9):e44238. Epub 2012 Sep 7.

48.

[Combination of bla(VIM-1) and qnrS2 on the same plasmid in Klebsiella oxytoca and Klebsiella pneumoniae isolates in Seville].

Rodríguez-Martínez JM, Conejo MC, Díaz de Alba P, López-Cerero L, Fernandez-Echauri P, Pascual A.

Enferm Infecc Microbiol Clin. 2012 May;30(5):246-8. doi: 10.1016/j.eimc.2011.09.020. Epub 2012 Jan 16. Spanish.

PMID:
22257559
49.

Impact of changes in CLSI and EUCAST breakpoints for susceptibility in bloodstream infections due to extended-spectrum β-lactamase-producing Escherichia coli.

Rodríguez-Baño J, Picón E, Navarro MD, López-Cerero L, Pascual A; ESBL-REIPI Group.

Clin Microbiol Infect. 2012 Sep;18(9):894-900. doi: 10.1111/j.1469-0691.2011.03673.x. Epub 2011 Oct 10.

50.

Assessment of the presence of extended-spectrum beta-lactamase-producing Escherichia coli in eggshells and ready-to-eat products.

Egea P, López-Cerero L, Navarro MD, Rodríguez-Baño J, Pascual A.

Eur J Clin Microbiol Infect Dis. 2011 Sep;30(9):1045-7. doi: 10.1007/s10096-011-1168-3. Epub 2011 Jul 14.

PMID:
21755280

Supplemental Content

Loading ...
Support Center